Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol dose for loss of consciousness and correlation with Narcotrend index by sequential method in different age groups
ChiCTR2300072477Phase 4Not yet recruiting
- Sponsor
- Zhongshan Boai Hospital
- Start
- Jun 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol in None (3 arms), sponsored by Zhongshan Boai Hospital. Primary endpoint: Loss of consciousness. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
ciprofol
Beyond the preview
Go deeper on ChiCTR2300072477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072477.